Skip to main content
. 2019 Aug 14;8(8):303. doi: 10.3390/antiox8080303
AAPH 2,2′-azo-bis-(2-methylpropionamidine) dihydrochloride
ABC ATP binding cassette
ADR Adriamycin, trade name of doxorubicin
BCRP breast cancer resistance protein
BHA butylated hydroxyanisole
BHT butylhydroxytoluen
CAA cellular antioxidant activity
COX-2 cyclooxygenase-2
DCFH-DA 2′,7′-dichlorofluorescin diacetate
DPPH 2,2-diphenyl-1-picrylhydrazyl
DMEM Dulbecco’s Modified Eagle’s Medium - high glucose
EMEM Eagle´s Minimum Essential Medium
FBS fetal bovine serum
FCR Folin–Ciocalteu reagent
FRAP ferric reducing ability of plasma
HepG2 human hepatocellular adenocarcinoma
HOC human ovarian adenocarcinoma
HOC/ADR human ovarian adenocarcinoma resistant to doxorubicin
IL-1 Interleukin-1
iNOS inducible isoform of nitric oxide synthases
LPS lipopolysaccharides
LOX lipoxygenase
MDR multidrug resistance
MEM Essential Medium Eagle no phenol red
NF-κB nuclear factor kappa-light-chain-enhancer of activated B cells
ORAC oxygen radical absorption capacity
P-gp P-glycoprotein
PBS Phosphate-buffered saline
RAW 264.7 mouse macrophages
RLU relative luminescence units
THTT thyroid hormone transmembrane transporters
TNF-α tumor necrosis factor alpha